Home › Narcolepsy › Ohio › Cincinnati
Narcolepsy clinical trials in Cincinnati, OH
7 studies for Narcolepsy are looking for participants at sites in and around Cincinnati (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
RecruitingPhase 3
- Intrepid Research, LLC, Cincinnati
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
RecruitingPhase 2/3
- Cincinnati, Ohio, Cincinnati
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
RecruitingPhase 2/3
- Alkermes Investigational Site, Cincinnati
- Alkermes Investigational Site, Cincinnati
A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH
RecruitingPhase 3
- Intrepid Research, Cincinnati
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
RecruitingPhase 3
- Alkermes Investigational Site, Cincinnati
A Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)
RecruitingPhase 2
- Takeda Site 13, Cincinnati
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
RecruitingPhase 2
- Cincinnati, Ohio, Cincinnati
Narcolepsy trials in other cities
- Miami, FL8 studies
- Austin, TX7 studies
- Charlotte, NC7 studies
- Columbia, SC6 studies
- Sugar Land, TX5 studies
- Orlando, FL5 studies
- San Antonio, TX5 studies
- Atlanta, GA5 studies
- Macon, GA4 studies
- Lansing, MI4 studies
- Los Angeles, CA4 studies
- Brandon, FL4 studies
Other studies in Cincinnati
- Non-Small Cell Lung Cancer31 studies
- Cancer (all types)26 studies
- Breast Cancer24 studies
- Heart Failure22 studies
- Metastatic Cancer21 studies
- Colorectal Cancer20 studies
- Obesity20 studies
- Acute Myeloid Leukemia20 studies
- Prostate Cancer19 studies
- Ovarian Cancer18 studies
- Lung Cancer18 studies
- Multiple Myeloma17 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.